Revenue
0 USD
2024 Q4 · USD
Fundies. English
THC Therapeutics, Inc.
EDGARAnnual consolidated revenue for 2024: about USD 0, using the latest reported figures. The previous period, 2023, was about USD 0.
Latest quarter
- Cash and cash equivalents
- 35 USD Source
Exact value
35 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 40.3 million shares Source
Exact value
40266149 shares
Reported share-count change
17.92% · 6.12 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
0 USD
2023-08-01 – 2024-07-31
Net income
-812 thousand USD
2023-08-01 – 2024-07-31
Exact inputs and evidence
Operating cash flow
-183 thousand USD
2023-08-01 – 2024-07-31
Exact inputs and evidence
- Operating cash flow: -269 USD · 2023-08-01 – 2023-10-31 Source
- Operating cash flow: -45397 USD · 2023-08-01 – 2024-01-31 Source
- Operating cash flow: -269 USD · 2023-08-01 – 2023-10-31 Source
- Operating cash flow: -182459 USD · 2023-08-01 – 2024-04-30 Source
- Operating cash flow: -45397 USD · 2023-08-01 – 2024-01-31 Source
- Operating cash flow: -183273 USD · 2023-08-01 – 2024-07-31 Source
- Operating cash flow: -182459 USD · 2023-08-01 – 2024-04-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-30.
Financial data available through: 2024-07-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage by financial measure
- Revenue: 6 of 11 periods available· newest 2024-07-31
- Operating income: 7 of 11 periods available· newest 2024-07-31
- Net income: 8 of 11 periods available· newest 2024-07-31
- Operating cash flow: 8 of 11 periods available· newest 2024-07-31
- capital expenditure: No compatible figures in this window
- Total assets: 6 of 11 periods available· newest 2024-07-31
- Total liabilities: 6 of 11 periods available· newest 2024-07-31
- Current assets: 6 of 11 periods available· newest 2024-07-31
- Current liabilities: 6 of 11 periods available· newest 2024-07-31
- Cash and cash equivalents: 6 of 11 periods available· newest 2024-07-31
- long term debt: No compatible figures in this window
- Shares outstanding: 6 of 11 periods available· newest 2024-07-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
USD 0Prior period
USD 0
–
Current period
USD 0
–
Exact inputs and evidence
0 − 0 = 0 USD
0 USD · 2022-08-01 – 2023-07-31
Inspect prior input Prior source0 USD · 2023-08-01 – 2024-07-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 424,526Prior period
−USD 387,036
–
Current period
−USD 811,562
–
Exact inputs and evidence
-811562 − -387036 = -424526 USD
-387036 USD · 2022-08-01 – 2023-07-31
Inspect prior input Prior source-811562 USD · 2023-08-01 – 2024-07-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 97,841Prior period
−USD 85,432
–
Current period
−USD 183,273
–
Exact inputs and evidence
-183273 − -85432 = -97841 USD
-85432 USD · 2022-08-01 – 2023-07-31
Inspect prior input Prior source-183273 USD · 2023-08-01 – 2024-07-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2024 2023-08-01 – 2024-07-31
- Revenue USD 0
- Cost of revenue USD 0
- Operating expenses USD 541,975
- Other operating costs Derived USD 0
- Operating income −USD 541,975
- Tax, interest and other Derived USD 269,587
- Net income −USD 811,562
Cash
- Operating cash flow −USD 183,273
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2019 Not shown: operating income or net income is not reported.
- 2020 Not shown: operating income or net income is not reported.
- 2021 Not shown: operating income or net income is not reported.
- 2022 Not shown: operating income or net income is not reported.
- 2023 Not shown: operating income or net income is not reported.
- 2024 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2019 2018-08-01 – 2019-07-31 | 0 | 26689910 Derived | -26689910 | -3382846 Derived | -23307064 | Unavailable | Source
|
| 2020 2019-08-01 – 2020-07-31 | 0 | 1390410 Derived | -1390410 | 540989 Derived | -1931399 | Unavailable | Source
|
| 2021 2020-08-01 – 2021-07-31 | 0 | 939977 Derived | -939977 | 945468 Derived | -1885445 | Unavailable | Source
|
| 2022 2021-08-01 – 2022-07-31 | 0 | 1746028 Derived | -1746028 | -227099 Derived | -1518929 | Unavailable | Source
|
| 2023 2022-08-01 – 2023-07-31 | 0 | 493912 Derived | -493912 | -106876 Derived | -387036 | Unavailable | Source
|
| 2024 2023-08-01 – 2024-07-31 | 0 | 541975 Derived | -541975 | 269587 Derived | -811562 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 0 2024
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Revenue | 0 |
|
| 2020 | Revenue | 0 |
|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 0 |
|
| 2023 | Revenue | 0 |
|
| 2024 | Revenue | 0 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Operating margin | Not reported |
|
| 2020 | Operating margin | Not reported |
|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | Not reported |
|
| 2023 | Operating margin | Not reported |
|
| 2024 | Operating margin | Not reported |
|
| 2019 | Net margin | Not reported |
|
| 2020 | Net margin | Not reported |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | Not reported |
|
| 2023 | Net margin | Not reported |
|
| 2024 | Net margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -183.3K 2024
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Operating cash flow | -329803 |
|
| 2020 | Operating cash flow | -587933 |
|
| 2021 | Operating cash flow | -388477 |
|
| 2022 | Operating cash flow | -418917 |
|
| 2023 | Operating cash flow | -85432 |
|
| 2024 | Operating cash flow | -183273 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
35,802.1% 2024
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Liabilities / assets | 244.1% |
|
| 2020 | Liabilities / assets | 2,142.9% |
|
| 2021 | Liabilities / assets | 595.2% |
|
| 2022 | Liabilities / assets | 1,554.8% |
|
| 2023 | Liabilities / assets | 25,579.9% |
|
| 2024 | Liabilities / assets | 35,802.1% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0× 2024
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Current assets / current liabilities | 0.36× |
|
| 2020 | Current assets / current liabilities | 0.02× |
|
| 2021 | Current assets / current liabilities | 0.11× |
|
| 2022 | Current assets / current liabilities | 0.01× |
|
| 2023 | Current assets / current liabilities | 0× |
|
| 2024 | Current assets / current liabilities | 0× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2017-08-01 – 2018-07-31 | −USD 6.14 million Exact valueExact value: -6139400 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 190,165 Exact valueExact value: -190165 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-08-01 – 2019-07-31 | −USD 23.31 million Exact valueExact value: -23307064 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 329,803 Exact valueExact value: -329803 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-08-01 – 2020-07-31 | −USD 1.93 million Exact valueExact value: -1931399 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 587,933 Exact valueExact value: -587933 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-02-01 – 2021-01-31 | −USD 449,875 Exact valueExact value: -449875 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.24 million Exact valueExact value: 2236163 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-08-01 – 2021-07-31 | −USD 1.89 million Exact valueExact value: -1885445 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 388,477 Exact valueExact value: -388477 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-08-01 – 2022-07-31 | −USD 1.52 million Exact valueExact value: -1518929 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 418,917 Exact valueExact value: -418917 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-08-01 – 2023-07-31 | −USD 387,036 Exact valueExact value: -387036 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 85,432 Exact valueExact value: -85432 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-08-01 – 2024-07-31 | −USD 811,562 Exact valueExact value: -811562 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 183,273 Exact valueExact value: -183273 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
53 filings · 1,977 latest values · 1,977 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001404935, 1404935, edgar:1404935
Also known as Aviation Surveillance Systems, Inc., Fairytale Ventures Inc, HARMONIC ENERGY, INC., THC THERAPEUTICS, INC., THC Therapeutics, Inc., THC Therapeutics, Inc.